Current Issues - Newsletter

January 2007

Message from Dr. Majeed

Sabinsa Corporation is now in its nineteenth year. 2006 was an eventful year for us. We received four US patents and two international patents, and continued to expand research efforts towards serving preventive and other health care needs in populations across the world. Glaucoma is a progressively degenerative disease of the optic nerve and is the second-leading cause of blindness in the world, affecting 67 million people globally. Sabinsa’s patented process helped to create a stable and safe solution of forskolin for ophthalmic use as a drug in treating glaucoma. We were granted permission by the Drugs Controller General of India to manufacture and market Ocufors an ophthalmic solution containing one percent forskolin, for the treatment of glaucoma. This is the first time that the government of India has approved a product developed by a private organization, from natural sources, for use as a pharmaceutical grade drug.

Dr.Mohammed Majeed

We continued to work with research institutes and universities at various geographical locations, to validate the safety and efficacy of our branded natural extracts and nutritional ingredients. A study with our Curcumin C3 Complex® at UCLA showed promising results in the potential prevention of Alzheimer’s disease, another at Vanderbilt University further confirmed the safety of SeleniumSeLECT® (L-Selenomethionine) for supplemental use in selenium replete populations.

We expanded operations in Europe and South East Asia, opening new offices in Langen, Germany and in the vicinity of Kuala Lumpur, Malaysia. Our research group at Sami Labs Ltd. Bangalore, India, undertook several custom synthesis, clinical research and contract R & D projects for global manufacturing companies last year. Clinical research projects were facilitated through the company's contract research arm, ClinWorld. Our expanded manufacturing facilities in Payson, Utah, will become operational in February 2007.

As a supplier of raw ingredients, we will continue in our efforts to establish and maintain quality standards, clinically validating ingredient health claims, and educating consumers on the health benefits of phytonutrients and nutritional actives. We have just completed our 3rd year of NSF audits for our manufacturing facilities. We will keep the spirit of innovation alive in the industry through sustained intellectual property creation and protection efforts. As always, we look forward to working with you this year and in the years to come, to bring quality dietary supplements, functional foods, cosmeceuticals and nutricosmetics to the global marketplace.

I take this opportunity to wish you a very Happy and Healthy 2007.

Sabinsa's BioPerine patent confirmed

The US Patent and Trademark Office has completed a formal review of Sabinsa Corporation's patent for black pepper extract, BioPerine®, and has found the intellectual property to be valid.

The corporation announced in November it was taking legal action against DNP International for allegedly infringing patents protecting the use of its BioPerine and Forslean extracts. Respect for intellectual property is critical in sustaining the spirit of research and innovation and in making these efforts economically worthwhile. Sabinsa Corporation has built a sizeable intellectual property portfolio and actively advocates the protection of intellectual property.

The patent review ensures that all claims outlined in this patent are valid, and that companies selling piperine containing black pepper extracts for the express or implied purpose of nutrient absorption enhancement are in violation of Sabinsa’s intellectual property.

Bioperine is a standardized black pepper extract that contains 95 percent of piperine, and is clinically proven to enhance the bioavailability of co-administered nutrients in formulations.

Ed Olson – Senior VP of Manufacturing

Ed Olson has joined Sabinsa Corporation as senior vice president of manufacturing. Olson will provide Sabinsa's customers with innovative ideas and practical solutions to help meet their manufacturing requirements and custom formulation needs. He will also oversee the expansion of Sabinsa's manufacturing facility in Payson, Utah.

EdOlson

Ed brings with him a wealth of knowledge and experience in the formulation and manufacture of nutritional supplements and will help Sabinsa’s customers determine and meet their needs in high volume granulations, drum-to-hopper and other custom blends, particle size reduction, roll compaction, custom formulations, and other specialized manufacturing modalities.

Prior to joining Sabinsa, Olson worked in the sales department of Cornerstone Research & Development, Inc., was the sales Vice President and a driving force for Alpine Health Industries and National Sales Manager for Alpha-Pak. Olson also ran his own company, Olson Nutritional Services, Inc., where he provided dietary supplement companies with assistance in product supply and development, labeling, and marketing.

Sabinsa’s Expanded Manufacturing Facility : Operational in February 2007

We are pleased to announce the scheduled completion of our new SABINSA MANUFACTURING facility in Payson, Utah.

This significant addition will extend our current contract manufacturing capabilities and capacity in contract and specialty powder processing. Our expansion includes high volume capacity in fluid bed granulations as well as custom drum-to-hopper and powder blends. Our services are not limited to only Sabinsa ingredients thereby providing our clients with a one stop shop for all their contract and custom processing needs.

Sabinsa Utah

In addition to the new building, the new construction will include analytical and microbiological laboratories as well as a pilot laboratory to facilitate product and scale-up development.

Our new facility will begin operations in February 2007. This facility incorporates some of the finest air handling and water purification systems in the industry and will complement the manufacturing standards of our many fine quality oriented customers.

Upon completion we will work quickly to obtain Australian TGA and other international regulatory certifications to better serve our international clients as well as our domestic clients who have a need but aren’t certified themselves.

With 100 scientists across the globe and additional nutrition industry specific expertise within our corporate group, SABINSA MANUFACTURING is uniquely positioned to provide our customers with innovative ideas and practical solutions to meet a wide variety of manufacturing requirements.

We have already begun discussions with some of our clients and would appreciate the opportunity to assist you.

For more information, please call your sales representative or feel free to contact Ed Olson directly at SABINSA MANUFACTURING in our Payson, Utah facility at 801-465-8400 or send him an E-mail at: ed@sabinsa.com

"The information presented in the "Current Issues" Newsletter from Sabinsa Corporation is for informational purposes only. It is abstracted from web and print media sources. Readers are advised to refer to the original sources for additional information".